Efficacy and safety of the dual GIP and GLP-1 receptor agonist tirzepatide for weight loss: a meta-analysis of randomized controlled trials
Although most frequently diagnosed in Japan, there have been cases diagnosed worldwide in patients of other ethnicities, including some predisposed individuals identified in Turkish and Sicilian populations (49)
All RNA transcriptomics data generated for this manuscript have been deposited in the NCBIs Gene Expression Omnibus database (GEO GSE293590)
After eight weeks of injections, it becomes difficult to remember exactly what happened during week three
It doesnt account for insurance, dosage, discounts, or markups
Provider follow-up may include: weight-loss pace, hydration, protein intake, bowel habits, energy level, muscle preservation and how well the current dose is tolerated